It’s available as a cartridge that’s attached to a reusable pen and ... purplebooksearch.fda.gov Genotropin (somatropin) for injection, for subcutaneous use. (2019). https://labeling.pfizer ...

A Pfizer biologic ... pre-filled injection pen. In Phase 3 testing in children, somatrogon met the main goal of showing that it was not inferior to daily injections of Genotropin as assessed ...

A billion dollar market opportunity Pfizer's Genotropin is one of the most widely-used human growth therapies, but a host of other companies, including market-share leader Novo Nordisk ...

Pfizer announced top-line results from its Phase 3B study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age (SGA) children 24–30 months old.

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study ...

A phase 3 trial has found Pfizer and Opko Health’s once-weekly growth hormone deficiency (GHD) treatment imposes less of a burden than the established daily drug Genotropin. The readout comes ...

Pfizer has agreed to pay nearly $35 million to settle charges for inappropriate marketing of the human growth hormone Genotropin. Pfizer has agreed to pay nearly $35 million to settle charges for ...

with the goal of transitioning patients from Pfizer's Genotropin, which has been facing competition from biosimilars. In addition, on June 23, the FDA approved Litfulo, making it the first drug on ...

In a bid to protect sales for its human growth hormone drug Genotropin, Pfizer licensed rights to a longer-lasting human growth hormone therapy, hGH-CTP, in December. This longer-lasting drug has ...